ICON plc completed the disposal of Symphony Health Solutions Corporation to HealthVerity on May 8, 2026, recording a $32.9 million loss and retaining a minority equity interest in HealthVerity. The company also executed a bridge secured credit facility, drawing down $500.0 million on July 15, 2026, to fully repay its maturing 2.875% Senior Secured Notes due July 2026. For the six months ended June 30, 2026, revenue increased to $4.1 billion from $4.05 billion in the prior year period, while net income declined significantly to $177.3 million from $364.3 million due to restructuring charges and the disposal loss. ICON plc operates as a global contract research organization providing outsourced clinical development services to pharmaceutical, biotechnology, medical device, and government clients.
